Atlas Trials

Principia Biopharma, a Sanofi Company

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Principia Biopharma, a Sanofi Company

RecordFirmDate
Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis (NCT04992546)Principia Biopharma, a Sanofi Company2021-08-13
Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants (NCT04748926)Principia Biopharma, a Sanofi Company2021-04-07
Pharmacokinetics (PK) of Rilzabrutinib (PRN1008) in Healthy Japanese and Caucasian Subjects (NCT06444191)Principia Biopharma, a Sanofi Company2021-01-04
Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP) (NCT04562766)Principia Biopharma, a Sanofi Company2020-12-14
A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008) (NCT06444204)Principia Biopharma, a Sanofi Company2020-11-02
Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants (NCT04520451)Principia Biopharma, a Sanofi Company2020-08-22
A Study of PRN1008 in Patients With Pemphigus (NCT03762265)Principia Biopharma, a Sanofi Company2019-01-08
A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP) (NCT03395210)Principia Biopharma, a Sanofi Company2018-03-22

Track Principia Biopharma, a Sanofi Company automatically

Every clearance here is in the API, with alerts when new ones post.